Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989;14:1477–86.
Verani MS, Mahmarian JJ. Myocardial perfusion scintigraphy during maximal coronary artery vasodilation with adenosine. Am J Cardiol 1991;67:12D-7D.
Leppo JA, Boucher CA, Okada RD, et al. Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion. Circulation 1982;66:649–57.
Gill JB, Miller D, Boucher CA, et al. Clinical decision making: dipyridamole-thallium imaging. J. Nucl Med 1986;27:132–7.
Brown BG, Josephson MA, Peterson RD, et al. Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery disease. Am J Cardiol 1981;48:1077–85.
Verani MS. Adenosine thallium-201 myocardial perfusion scintigraphy. Am Heart J 1991;122:269–78.
Verani MS, Mahmarian JS, Hixson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990;82:80–7.
Kinoshita S, Suzuki S, Yamashita S, et al. Thallium-201 myocardial scintigraphy after intravenous infusion of adenosine triphosphate disodium in the diagnosis of coronary artery disease [Abstract]. Presented at First International Congress of Nuclear Cardiology, Cannes, France, April 25–28, 1993.
Nguyen T, Heo J, Ogilby D, Iskandrian AS. Single-photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: correlation with coronary arteriography, exercise thallium imaging, and two-dimensional echocardiography. J Am Coll Cardiol 1990;16:1375–83.
Belardinelli L, West A, Crampton R, Berne RM. Chronotropic and dromotropic actions of adenosine. In: Berne RM, Rall TW, Rubio R, eds. The regulatory function of adenosine. The Hague: Martinus Nijhoff, 1983:378–98.
Beller GA. Dipyridamole cardiac imaging. JAMA 1991;265:633–8.
Beller GA, Holzgrefe HH, Watson DD. Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201. Circulation 1983;68:1328–38.
Gould KL. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation, I: physiologic basis and experimental validation. Am J Cardiol 1978;41:267–78.
Gould KL, Westcott JR, Albro PC, Hamilton GW. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation, II: clinical methodology and feasibility. Am J Cardiol 1978;41:279–87.
Iskandrian AS, Heo J. Pharmacologic stress testing. In: Zaret BL, Beller GA, eds. Nuclear cardiology: state of the art and future directions. St Louis: Mosby-Year Book, 1992:170–80.
Beer S, Heo J, Iskandrian AS. Dipyridamole thallium imaging. Am J Cardiol 1991;67:18D-26D.
Elliot BM, Robinson JG, Zellner JL, Hendrix GH. Dobutamine 201-T1 imaging: assessing cardiac risks associated with vascular surgery. Circulation 1991; 84(suppl):III-54–60.
Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993;21:1583–90.
Marwick T, Willemart B, D’Hondt AM, et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion: comparison of dobutamine and adenosine using echocardiography and Tc-99m MIBI single photon emission computed tomography. Circulation 1993;87:345–54.
Marwick T, D’Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy or both? J Am Coll Cardiol 1993;22:159–67.
Mason JR, Palac RJ, Freeman ML, et al. Thallium scintigraphy during dobutamine infusion: non-exercise dependent screening test for coronary disease. Am Heart J 1984;107:481–5.
Meretes IT, Sawada MB, Ryan T, et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: experience in 1,118 patients. Circulation 1993;88:15–9.
Pennell DJ, Underwood SR, Swanton RH, et al. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991;18:1471–9.
Pennell DJ, Underwood SR, Ell PJ. Safety of dobutamine stress for thallium-201 myocardial perfusion tomography in patients with asthma. Am J Cardiol 1993;71:1346–50.
Poldermans D, Fioretti PM, Forster T, et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 1993;87:1506–12.
Ogilby D, Iskandrian AS, Untereker W, Heo J, Nguyen TN, Mercuro J. Effect of intravenous adenosine infusions on myocardial perfusion and function. Hemodynamic angiographic and scintigraphy study. Circulation 1992;86:887–95.
Chan SY, Brunken RD, Czernin J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992;20:979–85.
Krivokapich J, Huang S-C, Schelbert HR. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects. using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol 1993;71:1351–6.
Krivokapich J, Smith GT, Huang SC, et al. N-13 ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989;80:1328–37.
Kern MJ, Deligonul U, Tatineni S, et al. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol 1991;18:718–29.
Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595–606.
Rossen JD, Quillen JE, Lopez AG, et al. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol 1991;18:485–91.
Rossen JD, Simonetti I, Marcus ML, et al. Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip. Circulation 1989;79:566–72.
Picano E, Lattanzi F, Masini M, et al. High-dose dipyridamole-echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986;8:848–54.
Lee J, Heo J, Ogilby JD, Cave V, Iskandrian B, Iskandrian AS. Atrioventricular block during adenosine thallium imaging. Am Heart J 1992;123:1569–74.
Casole PN, Guiney TE, Strauss HW, Boucher CA. Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging. Am J Cardiol 1988;62:799–802.
Stern S, Greenberg ID, Corne RA. Quantification of walking exercise required for improvement of dipyridamole thallium-201 image quality. J Nucl Med 1992;33:2061–6.
Ranhosky A, Kempthorne-Rawson J, Intravenous Dipyridamole Thallium Imaging Study Group. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 1990;81:1205–9.
Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging in 9,256 patients: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol (in press).
Abreu A, Mahmarian JJ, Nishimura S, Boyce TM, Verani MS. Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol 1991;18:730–5.
Nishimura S, Kimball KT, Mahmarian JJ, Verani MS. Angiographic and hemodynamic determinants of myocardial ischemia during adenosine thallium-201 scintigraphy in coronary artery disease. Circulation 1993;87:1211–9.
Picano E, Masini M, Lattanzi F, et al. Short term reproducibility of exercise testing in patients with ST segment elevation and different responses to the dipyridamole test. Br Heart J 1988;60:281–6.
Iskandrian AS, Heo J. Myocardial ischemia during pharmacologic coronary vasodilatation: a concept in search of definition. Cathet Cardiovasc Diagn 1989;18:65–6.
Iskandrian AS. Myocardial ischemia during pharmacological stress testing [Editorial]. Circulation 1993;87:1415–7.
Gupta NC, Esterbrooks DJ, Hilleman DE, Mohuiddin SM. Comparison of adenosine and exercise thallium-201 SPECT myocardial perfusion imaging. J Am Coll Cardiol 1992;19:248–56.
Coyne EP, Belvedere DA, Vande Streek PR, et al. Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise thallium testing in the diagnosis of coronary artery disease. J Am Coll Cardiol 1991;17:1289–94.
Leppo JA, Boucher CA, Okada RD, Newell JB, Strauss HW, Pohost GM. Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion. Circulation 1982;66:649–57.
Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease. J Am Coll Cardiol 1991;18:736–45.
Allman KC, Berry J, Sucharski LA, et al. Determination of extent and location of coronary artery disease in patients without prior myocardial infarction by thallium-201 tomography with pharmacologic stress. J Nucl Med 1992;33:2067–73.
Iskandrian AS, Heo J, Nguyen T, et al. Assessment of coronary artery disease using single-photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia. Am J Cardiol 1991;67:1190–4.
Iskandrian AS, Heo J, Lemlek J, et al. Identification of high-risk patients with left main and three-vessel coronary artery disease by adenosine-single photon emission computed tomographic thallium imaging. Am Heart J 1993;125:1130–5.
Iskandrian AS, Heo J, Nguyen T, Lyons E, Paugh E. Left ventricular dilation and pulmonary thallium uptake after single-photon emission computed tomography using thallium-201 during adenosine induced coronary hyperemia. Am J Cardiol 1990;66:807–11.
Civelek AC, Gozukara I, Durski K, et al. Detection of left anterior descending coronary artery disease in patients with left bundle branch block. Am J Cardiol 1992;70:1565–70.
O’Keefe JH, Bateman TM, Barnhart CS. Adenosine thallium-201 is superior to exercise thallium-201 for detecting coronary artery disease in patients with left bundle branch block. J Am Coll Cardiol 1993;21:1332–8.
Gupta NC, Esterbrooks DM, Shiue C, Mohiuddin S, Hilleman D, Frick MD. Utility of adenosine PET (perfusion/metabolic) imaging in patients with acute myocardial infarction following thrombolytic therapy. Radiology 1990;177:234–5.
Yonekura Y, Tamaki N, Senda M, et al. Detection of coronary artery disease with ammonia and high-resolution positron-emission computed tomography. Am Heart J 1987;113:645–54.
Schelbert HR, Wisenberg G, Phelps ME, et al. Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in man with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol 1982;49:1197–207.
Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR. Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Intern Med 1992;116:190–6.
Coma-Canella I, Martinez MG, Rodrigo F, et al. The dobutamine stress test with thallium-201 single photon emission computed tomography and radionuclide angiography: post infarction study. J Am Coll Cardiol 1993;22:399–406.
Zoghbi WA, Cheirif J, Kleiman NS, et al. Diagnosis of ischemic heart disease with adenosine echocardiography. J Am Coll Cardiol 1991;18:1271–9.